Results 71 to 80 of about 21,381 (225)
Changes in the diagnosis of glomerular diseases in east China: a 15-year renal biopsy study
Background: There have been some gradual changes in the distribution of renal biopsy pathological diagnoses during recent years. This study aimed to show changes in renal disease prevalence in China by investigating 10 patients diagnosed at our Kidney ...
Qin Zhou +12 more
doaj +1 more source
Recurrence of glomerulonephritis is the third-leading cause of allograft loss. Graft loss due to IgA nephropathy occurs in 10% at 10-year follow-up.
Umesh Lingaraj +4 more
doaj +1 more source
Background The outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has been followed by many reports of the development and relapse of autoimmune diseases associated with SARS-CoV-2 vaccination.
Miyako Fukuda +4 more
doaj +1 more source
Global kidney health: Are we failing the silent pandemic?
Abstract Chronic kidney disease (CKD), although not infectious, has a sharply rising global incidence, alarming rates of death and disability, and the potential to disrupt health systems and economies. Thus, it demands the urgency and global attention of past pandemics.
Taewon Yi +2 more
wiley +1 more source
IgA Nephropathy in North West Frontier Province of Pakistan
Background: IgA nephropathy is the most common form of glomerulonephritis in the world. The extent to which IgA nephropathy is diagnosed depends upon the local attitude towards urine testing and renal biopsy.
Mohammad Noor +4 more
doaj
This 20‐year retrospective study reveals a significant increase in renal biopsy utilization and a pivotal shift in biopsy‐proven renal disease among Chinese elderly patients. Secondary glomerular nephropathy (particularly diabetic nephropathy and hypertensive nephropathy) has surpassed primary glomerular nephropathy as the leading biopsy‐proven ...
Shasha Han +4 more
wiley +1 more source
Shifting From Systemic to Precision‐Targeted Complement Therapies: Opportunities and Hurdles
Complement therapeutics have expanded considerably, but systemic inhibitors remain limited by infection risks, breakthrough events, and loss of physiological functions. Emerging targeted approaches aim for organ‐, tissue‐, or cell‐specific modulation of complement activity, potentially offering greater precision while reducing treatment burden and ...
Marco Mannes +2 more
wiley +1 more source
Primary glomerulonephritis in Hong Kong [PDF]
The clinical presentation and natural history of 428 patients with biopsy-proven primary glomerulonephritis were reviewed. Minimal change glomerulonephritis presented with the nephrotic syndrome and followed a benign course. Membranous glomerulonephritis
Chan, MK, Yin, PD, Chan, KW
core
Schistosoma mansoni associated glomerulopathy with IgA mesangial deposits: case report
Introduction: Renal involvement is a severe form of schistosomiasis and occurs in 10% to 15% of patients with the hepatosplenic form of the disease. Nephrotic syndrome is the most common clinical presentation.
Fabiana Oliveira Gonçalves +2 more
doaj +1 more source

